Since dendritic cells (DCs) play a critical role in establishing antigen-specific adaptive immune responses, in the past several years, therapeutic strategies using genetically modified DCs against cancer and infectious diseases have attracted increasing attention. In the present study, we demonstrated that RGD fiber-mutant adenovirus vector (AdRGD) exhibited markedly superior gene transduction efficiency in mouse bone marrow-derived DCs (mBM-DCs) compared to conventional adenovirus vector (Ad). Likewise, this vector exhibited superior major histocompatibility complex class I-restricted presentation of antigen derived from the delivered gene in mBM-DCs. In order to investigate the effect of Ad-infection on the DC-differentiation process (maturation), we used three types of AdRGD and three conventional Ad to transduce mBM-DCs. These vectors carried either no transgene, LacZ gene, or gp100 gene. Infection by any of the Ad vectors enhanced the expression of MHC class II molecules in mBM-DCs. CD80, CD86, and CD40 expression and IL-12 production were more efficient in AdRGD-infected mBM-DCs than in conventional Adinfected cells. Contrary to our expectations, endocytotic activity of mBM-DCs decreased only slightly upon Ad-infection, whereas antigen uptake by lipopolysaccharide (LPS)-driven mature mBM-DCs was significantly impaired. However, our reverse transcription-polymerase chain reaction analysis revealed that Ad-infection resulted in the upregulation of the chemokine receptor CCR7 and downregulation of CCR6 in mBM-DCs and LPS-stimulated cells. We, therefore, concluded that Ad-infection directly influenced DC-maturation, although the effects were milder than under LPS-stimulation. In addition, this change in the immunologic properties of DCs resulted primarily from an increase in the number of Ad-particles capable of invading the cells rather than from the expression of foreign genes. AdRGD-infection caused greater induction of maturation than conventional Adinfection, irrespective of the type of transgene inserted.
D endritic cells (DCs) of hematopoietic origin are widely distributed throughout the peripheral tissues of a living body, and play a key function in the immune surveillance system. [1] [2] [3] Immature DCs efficiently capture and process both endogenous and exogenous antigens. Antigen exposure induces changes in the microenvironment of peripheral tissues, which leads to the production of proinflammatory cytokines. Likewise, these changes result in alterations in chemokine receptors that are expressed on DCs and which are important in the migration of DCs from peripheral tissues to the T-cell-dependent areas of the draining lymph nodes. During this migration, DCs upregulate the expression of a variety of surface molecules, such as major histocompatibility complex (MHC) molecules and costimulatory molecules, which allows them to interact with and activate naive antigen-specific T cells. As a result of these properties, DCs are ideal for generating a primary immune response against cancer and infectious diseases. Thus, a number of DC vaccination strategies are being designed and developed by various research organizations.
Although the pulsing of antigenic peptides has been used for antigen delivery to DCs in clinical trials of DC-based immunotherapy, [4] [5] [6] the transduction of gene coding antigens into DCs has only recently attracted attention. This method takes advantage of the natural properties of DCs as optimal immunological adjuvants and uses endogenous antigen gene expression to provide continuously antigenic epitopes for both MHC class Iand II-restricted expression. 7, 8 Furthermore, gene transduction into DCs is an attractive technology for developing effective DC-based immunotherapy, because functional modification of DCs by cytokine genes or costimulatory molecule genes has already been demonstrated. [9] [10] [11] [12] [13] Since the efficiency of foreign gene transduction into DCs is very low, even when an adenovirus vector (Ad) is used, the establishment of a new vector system that can improve gene transduction into DCs is desirable. [14] [15] [16] The internalization of Ad into target cells is mediated by at least two distinct cell receptors. Ad first attaches to the cell through an interaction between the carboxy terminus of the fiber knob of Ad particles and a cell surface receptor, known as the coxsackie-adenovirus receptor (CAR). [17] [18] [19] Following the high-affinity binding to CAR, a lower-affinity interaction between a v b 3 -or a v b 5 -integrins and the Arg-Gly-Asp (RGD) motif in the Ad-penton base facilitates internalization of the virion by receptormediated endocytosis through clathrin-coated vesicles. [20] [21] [22] At 10 minutes after internalization, Ad penetrates into the cytoplasm and the recombinant viral DNA is delivered to the nucleus. Penetration of the cytoplasm involves a pH-dependent conformational change in the Ad-penton base and an interaction with a v b 5 -integrins. 21 , 23 We previously reported that mouse DC lines and human normal DCs express little or no CAR. We also found that RGD fiber-mutant Ad (AdRGD), which targets a v -integrin upon attachment to cells by insertion of the RGD peptide into the HI loop of the fiber knob, exhibited extremely efficient transduction compared to conventional Ad. 24 Moreover, a mouse DC line (DC2.4 cells) that was transduced with the ovalbumin (OVA) gene by AdRGD, elicited a more efficient OVA-specific immune response in vaccinated mice than a cell line transduced by conventional Ad. 25 Although these results suggest that increased gene transduction efficiency by AdRGD would improve the efficacy of DC-based gene immunotherapy, the use of primary DCs rather than a continuously proliferating DC line is desirable. In addition, detailed analysis of DCs transduced by AdRGD is required before DCbased gene immunotherapy using AdRGD can be applied clinically.
In the present study, we evaluated the expression of CAR and a v -integrins on mouse bone marrow-derived DCs (mBM-DCs) and compared gene transduction efficiency in these primary DCs using AdRGD and conventional Ad. Additionally, immunological properties, such as antigen presentation via MHC class I molecules and the maturation state, of mBM-DCs infected with both types of Ad were investigated.
Materials and methods

Generation of mBM-DC
Female C57BL/6 mice, aged 7-8 weeks, were purchased from SLC Inc. (Hamamatsu, Japan) and held under specified pathogen-free conditions. The method for DC cultivation was adapted from that of Lutz et al. 26 and slightly modified. Briefly, bone marrow cells flushed from the femurs and tibias of mice were seeded at 5 Â 10 6 cells per sterile 100-mm bacterial grade culture dish in 10 ml of RPMI 1640 containing 10% heat-inactivated fetal bovine serum (FBS), 40 ng/ml recombinant murine granulocytemacrophage colony-stimulating factor (Pepro Tech EC LTD., London, England), 50 mM 2-mercaptoethanol, and antibiotics. On day 3, another 10 ml of culture medium was added to the dish for medium replenishment. On day 6, 10 ml of the culture supernatant was collected and centrifuged at 1500 rpm for 5 minutes at room temperature, and the pellet was resuspended in 10 ml of fresh culture medium, and returned to the original dish to conserve unattached cells. mBM-DCs, 8 days old, (nonadherent cells) were harvested and used as immature DCs in subsequent experiments. Flow cytometric analysis indicated that more than 85% of the resulting cell population displayed characteristic DC surface markers, including I-A b and CD11c (data not shown). mBM-DCs cultured for more than 24 hours in media containing 1 mg/ ml lipopolysaccharide (LPS; Nacalai Tesque, Inc., Kyoto, Japan) were used as positive controls for phenotypical DC-maturation.
Reverse transcription-polymerase chain reaction (RT-PCR) analysis of CAR and integrins
Total RNA was isolated from mBM-DC, lung, and liver using Sepasol-RNA I Super (Nacalai Tesque) according to the manufacturer's instructions. RT proceeded for 60 minutes at 421C in a 50 ml reaction mixture containing 5 mg total RNA treated with DNase I, 10 ml 5 Â RT buffer, 5 mM MgCl 2 , 1 mM dNTP mix, 1 mM random hexamers, 1 mM oligo(dT), and 100 U ReverTra Ace (Toyobo Co., Ltd, Osaka, Japan).
PCR amplification of the mouse CAR, mouse integrins (a v , b 3 , and b 5 ), and mouse b-actin transcripts proceeded in 50 ml of a reaction mixture containing 1 ml of RTmaterial, 5 ml 10 Â PCR buffer, 1.25 U Taq DNA polymerase (Toyobo Co., Ltd), 1.5 mM MgCl 2 , 0.2 mM dNTP, and 0.4 mM primers. The sequences of the specific primers used for PCR amplification are: 24 The PCR products were electrophoresed through a 3% agarose gel, stained with ethidium bromide, and visualized under ultraviolet light. EZ Loadt (BIO-RAD, Tokyo, Japan) was used as a 100 bp molecular ruler.
Preparation and titration of recombinant Ad
The replication-deficient Ad used in the present study was based on adenovirus serotype 5 and contained a deletion in early regions 1 and 3. The RGD sequence was introduced into the HI loop of the fiber knob using the two-step method developed by Mizuguchi et al. 27, 28 Both conventional Ad and AdRGD, which carried the desired coding cDNA under the control of the cytomegalovirus promoter, were constructed by an improved in vitro ligation method as described. [28] [29] [30] Enhanced green fluorescent protein (EGFP) gene derived from pEGFP-N1 (Clontech, Palo Alto, CA), OVA gene derived from pAcneo-OVA 31 (kindly provided by Dr MJ Bevan; Department of Immunology, Howard Hughes Medical Institute, University of Washington, Seattle, WA), the Escherichia coli b-galactosidase (LacZ) gene derived from pCMVb (Clontech), and human melanoma-associated antigen (gp100) gene derived from pAx1-CA h-gp100 (kindly provided by Dr H Hamada; Department of Molecular Medicine, Sapporo Medical University, Sapporo, Japan) were used as cDNA sources. Ad-Null and AdRGD-Null were identical vectors, but contained no transgenes. Both types of Ad were propagated in HEK293 cells, purified by two rounds of CsCl density centrifugation, dialyzed, and stored at À801C. Titers of infective Ad particles were evaluated by end point dilution method using HEK293 cells.
Infection of mBM-DCs by Ad
On day 8 of cultivation, mBM-DCs were resuspended at a concentration of 5 Â 10 6 cells/ml in FBS-free RPMI 1640 and placed in a 15-ml conical tube. Ad was added at various multiplicities of infection (MOI), the suspension was mixed well, and the tube was incubated at 371C for 2 hours with occasional gentle agitation. Nine volumes of RPMI 1640 supplemented with 10% FBS, 50 mM 2-mercaptoethanol, and antibiotics were then added, and the cells were transferred to bacterial grade culture dishes.
Analysis of gene transfer
mBM-DCs were infected with EGFP-expressing AdRGD and conventional Ad (AdRGD-EGFP and Ad-EGFP, respectively) at MOI of 10, 50, and 100. After 2 days cultivation, gene transduction efficiency and gene expression intensity were assessed by flow cytometry on a FACScalibur flow cytometer using CellQuest software (Becton Dickinson, Tokyo, Japan), acquiring 10,000 events by forward and side scatter gating to exclude cell debris.
Antigen presentation assay
AdRGD-OVA-or Ad-OVA-infected mBM-DCs were seeded on a 96-well flat-bottom culture plate at a density of 1 Â 10 5 cells/well. After 2 days, each well was washed twice by phosphate-buffered saline (PBS), and the cells were cocultured with 1 Â 10 5 cells/well specific T-T hybridoma against OVA + H-2K b (CD8-OVA 1.3 cells 32 ; kindly provided by Dr CV Harding; Department of Pathology, Case Western Reserve University, Cleveland, OH) at 371C for 20 hours. The response of stimulated CD8-OVA 1.3 cells was assessed by determining the amount of IL-2 released into an aliquot of culture medium (100 ml) using a murine IL-2 ELISA KIT (Biosource International, Camarillo, CA).
Analysis of surface marker expression
All antibodies used in the present study were purchased from Pharmingen (San Diego, CA). mBM-DCs were infected with various Ads at an MOI of 50. At 24 hours after infection, cell phenotype was confirmed by flow cytometric analysis. Briefly, 1 Â 10 6 cells in 100 ml staining buffer (PBS containing 0.1% bovine serum albumin and 0.01% NaN 3 ) were incubated for 30 minutes on ice with the anti-FcgRII/III monoclonal antibody (2.4G2) to block nonspecific binding of the subsequently used antibody reagents. The cells were resuspended in 100 ml staining buffer and incubated for 30 minutes on ice using the manufacturer's recommended amounts of biotinylated antibodies: AF6-120.1 (anti-I-A b ), 16-10A1 (anti-CD80), GL1 (anti-CD86), and 3/23 (anti-CD40). The cells were then resuspended in 100 ml staining buffer containing phycoerythrin-conjugated streptavidin at a 1:200 dilution, and nonspecific binding was measured using phycoerythrin-conjugated streptavidin alone. After incubation for 30 minutes on ice, 10,000 events of the stained cells were analyzed for surface phenotype by flow cytometry. Between all incubation steps, cells were washed three times with staining buffer.
Antigen uptake assay mBM-DCs infected with various Ads at an MOI of 50 were cultured for 48 hours, and then resuspended at 5 Â 10 6 cells/ml in ice-cold PBS containing 1 mg/ml fluorescein isothiocyanate (FITC)-dextran (MW: 50,800; Sigma Chemical Co., St Louis, MO). The cells were incubated at 37 or 41C to determine background uptake. After 1 hour, the cells were washed extensively with icecold PBS and analyzed by flow cytometry.
Quantitation of IL-12 p70-secretion and RT-PCR analysis of IL-12 p40 and chemokine receptors
After gene transduction by various Ads at an MOI of 50, mBM-DCs were seeded on 96-well culture plates at 1 Â 10 5 cells/100 ml/well and then cultured for 24 or 48 hours. The IL-12 p70 in these supernatants was assayed by the murine IL-12 p70 ELISA KIT (Biosource International).
Characteristics of DCs infected with RGD fiber-mutant Ad N Okada et al At 24 hours after infection, total RNA was isolated from the cells cultured on bacterial grade culture dishes, and then RT reaction using DNase I-treated total RNA as the template was performed as described above. PCR amplification of the mouse IL-12 p40 transcripts was performed using the following specific primer set: forward, 5 0 -ctc acc tgt gac acg cct ga-3 0 ; reverse, 5 0 -cag gac act gaa tac ttc tc-3 0 . After denaturation for 2 minutes at 941C, 30 cycles of denaturation for 60 seconds at 941C, annealing for 60 seconds at 481C, and extension for 60 seconds at 721C were repeated and followed by completion for 4 minutes at 721C. The expected PCR product size was 431 bp. To ensure the validity of the procedure, RT-PCR was performed on the same samples using specific primers for b-actin as described above. PCR amplification of the mouse chemokine receptors was performed using CytoXpress Multiplex PCR Kit (Biosource International) according to the manufacturer's instructions. Electrophoresis of all PCR products was performed as described above.
Results
Gene transduction efficiency and expression intensity in mBM-DCs
We assessed the levels of CAR and integrins mRNA in mBM-DCs by RT-PCR analysis (Fig 1) . CAR cDNA was not detected in mBM-DCs, whereas murine lung and liver, which were easily transduced by conventional Ad, expressed CAR mRNA. In contrast, a v -, b 3 -, and b 5 -integrin cDNA was amplified from mBM-DCs, lung, and liver. These findings are in agreement with the basic mechanisms of the Ad entry pathway [17] [18] [19] [20] [21] [22] [23] and support the notion that absence of CAR expression is a major cause of the relative resistance to Ad-mediated gene transfer in mBM-DCs as well as mouse DC lines and human DCs described in our previous report. 24 In addition, the targeting of a v -integrins by AdRGD during cell attachment is an attractive strategy for efficient gene transduction into mBM-DCs.
To compare the efficiency of foreign gene transduction and expression in mBM-DCs, we performed flow cytometric analysis using AdRGD-EGFP or Ad-EGFP. As shown in Figure 2 , both the transduction efficiency (percentage of M1-gated) and the expression intensity (mean fluorescence intensity; MFI) of the EGFP reporter gene in mBM-DCs infected by AdRGD-EGFP or Ad-EGFP increased in an MOI-dependent manner, and resulted in 7-to 10-fold differences in MFI at MOI of 50 and 100. AdRGD-EGFP at an MOI of 50 or 100 successfully transferred the EGFP gene into about 80% of mBM-DCs, whereas only 35% of mBM-DCs infected with Ad-EGFP were positive for EGFP expression under the highest infection condition (MOI of 100). In addition, AdRGD-EGFP at an MOI of 10 exhibited almost equal transduction efficiency and expression intensity in mBMDCs as that obtained by infection with Ad-EGFP at an MOI of 100. Cell viability was not affected by infection with either Ad type under these experimental conditions (data not shown).
MHC class I-restricted antigen presentation by mBM-DCs transfected with OVA gene using conventional Ad or AdRGD
The efficiency of antigen presentation via MHC class I molecules was compared between mBM-DCs infected by Ad-OVA and AdRGD-OVA on postinfection day 2 by measuring the production of IL-2 by CD8-OVA 1.3 cells specific for OVA peptides bound to MHC class I molecules (Fig 3) . The mBM-DCs infected with AdRGD-OVA presented OVA-peptides on MHC class I molecules in an MOI-dependent manner and more efficiently than Ad-OVA-infected mBM-DCs. This resulted in 2.5-to 3-fold differences in the levels of MHC class I-restricted antigen presentation. The difference between mBM-DCs transfected by conventional Ad and AdRGD correlated with gene transduction efficiency (percentage of M1-gated) of both Ad types, as shown in Figure 2 . This strongly suggested that the increased number of OVA gene-positive cells was directly linked to the enhancement of MHC class I-restricted antigen presentation by AdRGD-OVA-infected mBM-DCs.
Surface marker expression levels in mBM-DCs infected by various Ads
Immature cells were cultured in media containing 1 mg/ml LPS for more than 24 hours to produce phenotypically mature mBM-DCs. Both populations of mBM-DCs demonstrated typical DC morphology (data not shown). Phenotypical changes in mBM-DCs infected with AdNull, Ad-LacZ, Ad-gp100, or the corresponding AdRGDs at an MOI of 50 were examined by flow cytometry at 24 hours postinfection ( Table 1) . The LPS- 1-3 mBM-DCs infected with the three AdRGDs exhibited markedly enhanced expression of the MHC class II molecules, CD80, and CD86, as is seen in mature mBM-DCs. On the other hand, moderate enhancement of MHC class II expression and slight increases in CD80 and CD86 expression were observed in conventional Adinfected mBM-DCs. In addition, although expression levels observed under LPS-stimulation were not attained, infection with AdRGD increased the expression of CD40. This increase was not observed in cells infected with conventional Ad.
Endocytotic activity of mBM-DC infected with various Ads
As shown in Figure 4 , immature mBM-DCs exhibited rapid uptake of FITC-dextran at 371C. The low fluorescence intensity derived from internalized FITCdextran in immature mBM-DCs incubated at 41C demonstrated that this uptake was caused by endocytosis. The endocytotic activity of mBM-DCs was markedly decreased by LPS-driven maturation. On the other hand, mBM-DCs infected with various Ads at an MOI of 50 showed only slight decreases in fluorescence intensity at 48 hours postinfection. Similar changes in intensity were Characteristics of DCs infected with RGD fiber-mutant Ad N Okada et al observed in mBM-DCs at 24 hours after Ad-infection (data not shown).
IL-12 secretion from mBM-DCs infected with various Ads
We examined the effect of Ad-infection on IL-12 p40 mRNA expression levels and IL-12 p70 secretion levels in mBM-DCs by RT-PCR analysis and ELISA, respectively (Fig 5) . IL-12 p70 is a heterodimeric active form of IL-12, which consists of p35 and p40. Transcription of IL-12 p40 in mBM-DCs was upregulated 24 hours after Ad infection and LPS treatment. The degree of upregulation in AdRGD-infected mBM-DCs was superior to that in cells infected with conventional Ad. IL-12 p70 secretion from 24 hours to 48 hours after infection by AdRGD-infected mBM-DCs was remarkably higher than after infection by conventional Ad-infected cells, although the amount of IL-12 p70 accumulation in culture medium by 24 hours post-Ad infection was very low in both cell types. Changes in chemokine receptor mRNA expression in mBM-DCs infected with various Ads were analyzed by multiplex RT-PCR at 24 hours after infection (Fig 6) . PCR products derived from mRNA of CCR1, CCR2, CCR5, CCR6, CCR7, and CXCR4 were detected in immature (naive) mBM-DCs. Although the types of chemokine receptors expressed in mature mBM-DCs treated with LPS were identical to those found in immature mBM-DCs, a slight upregulation of CCR7 mRNA expression and a slight downregulation of CCR6 mRNA expression were observed. No changes were observed in CCR1, CCR2, CCR5, and CXCR4 mRNA expression levels between immature and mature mBM-DCs. The expression levels of each chemokine receptor mRNA in Ad-infected mBM-DCs resembled those in mature mBM-DCs rather than those in immature mBM-DCs, regardless of the fiber or transgene type.
Discussion
DCs are the most potent antigen-presenting cells and are uniquely capable of presenting novel antigens to naive T cells to initiate and modulate immune responses. [1] [2] [3] The ability to generate large numbers of DCs in vitro in the presence of appropriate cytokine cocktails using either human monocyte precursors in peripheral blood or stem cell progenitors in rodent bone marrow 26, 33, 34 has enhanced the testing of various immunotherapies that use DCs as ''nature's adjuvant'' and which target immunological repression of cancer or infectious diseases. In recent years, Ad has been widely used for continuous antigen delivery to DCs because of its superior gene transduction efficiency. 35 However, the current focus on DC-based gene immunotherapy has shed light on the damage to DCs caused by adenoviral toxicity caused by the extremely high and potentially cytopathic doses of Ad that are required for efficient gene transduction. We Figure 6 Expression pattern of chemokine receptors mRNA in various Ad-infected mBM-DCs. mBM-DCs were infected with six types of Ad at an MOI of 50 for 2 hours. At 24 hours after infection, total RNA was isolated from each cell, and then RT-PCR analysis of chemokine receptors was performed using CytoXpress Multiplex PCR kit.
Characteristics of DCs infected with RGD fiber-mutant Ad N Okada et al previously reported that little or no expression of CAR, the primitive Ad-receptor, was the major cause of resistance to Ad-mediated gene transfer in mouse DC lines and human normal DCs. We also found that AdRGD, which targets a v -integrins during cell attachment, could attain highly efficient gene transduction into these cells at noncytotoxic doses. 24 In the present study, we therefore compared gene transduction efficiency and immunological characteristics of AdRGD-and conventional Ad-infected mBM-DCs in order to demonstrate the usefulness of AdRGD for DC-based gene immunotherapy.
RT-PCR analysis revealed that mBM-DCs did not express CAR mRNA, whereas a v -, b 3 -, and b 5 -integrin could be detected by PCR (Fig 1) . Although we were unable to examine the expression of CAR on the surface of mBM-DCs, we surmised that expression was low because of the previously reported relation between the amount of CAR on the cell surface and mRNA expression levels. 36, 37 In fact, although conventional Ad at an MOI of 100 exhibited only 35% of gene transduction efficiency in mBM-DCs, AdRGD markedly improved both transduction efficiency (2.4-fold higher) and expression intensity (7-fold higher) under the same infection conditions (Fig 2) . Furthermore, AdRGD at an MOI of 10 unexpectedly delivered an equivalent amount of foreign gene into mBM-DCs as conventional Ad at an MOI of 100. These findings demonstrate that AdRGD is an excellent vector system for gene manipulation of mBM-DCs.
For vaccines and immunotherapies against cancer and infectious diseases, effective induction of the antigen-specific cytotoxic T lymphocyte (CTL) response is more important than the enhancement of the humoral immune response. [38] [39] [40] Since priming of CTL responses requires MHC class I-restricted presentation of the relevant antigen by DCs capable of providing costimulatory signals, efficient antigen delivery to the MHC class I pathway in DCs is critical for establishing effective host immunity. MHC class I-presented peptides are derived in most situations exclusively from endogenous antigens synthesized by cells, including DCs. Therefore, gene delivery to DCs provides an intracellular source of antigen for efficient and persistent loading of MHC class I molecules. The mBM-DCs transduced with the OVA gene by AdRGD showed more efficient MHC class I-restricted OVA presentation than cells transduced with conventional Ad, reflecting the dominance of gene transduction in mBM-DCs by AdRGD (Fig 3) . This difference between AdRGD-OVA-and Ad-OVA-infected mBM-DCs in the levels of antigen presentation via MHC class I molecules was in agreement with our previous results using the mouse DC line, DC2.4 cells. 25 Since AdRGD-OVA-infected DC2.4 cells elicited a more effective OVA-specific CTL response in vaccinated mice than Ad-OVA-infected DC2.4 cells, 25 we expected that mBM-DCs transduced by AdRGD would be superior to those transduced by conventional Ad in the induction of an antigen-specific immune response. At present, we are comparing the vaccine efficacy and therapeutic effects of mBM-DCs that contain a gp100 gene introduced by either AdRGD or conventional Ad in a mouse melanoma model.
In general, immature DCs, which have a great proclivity for endocytosis, do not effectively induce primary immune responses. However, the expression of MHC and costimulatory molecules important for successful antigen presentation is enhanced in DCs by maturation signals. [1] [2] [3] Furthermore, mature DCs increase the amount of IL-12 secretion, which is important for activation of cellular immunity, [41] [42] [43] and gain the ability to migrate to regional lymph nodes by changing the expression pattern of chemokine receptors. [40] [41] [42] [43] [44] [45] [46] Therefore, it is desirable for promoting the efficacy of DC-based immunotherapy that antigen delivery to DCs is accompanied by DC-maturation, which leads to optimal T-cell activation. Maturation can be triggered by multiple stimuli, including contact components of bacteria and viruses, proinflammatory cytokines, and CD40-CD40L signaling. [47] [48] [49] [50] Since Ad contains viral components, we sought to understand what effects Ad-infection would have on the maturation status of DCs.
Phenotypical analysis revealed that both AdRGDinfection and conventional Ad-infection adequately enhanced the expression of MHC class II molecules in mBM-DCs that were equivalent to mature mBM-DCs. Likewise, upregulation of CD80, CD86, and CD40 in AdRGD-infected mBM-DCs was substantially higher than in conventional Ad-infected cells (Table 1) . Endocytotic activity, which was highest in immature mBM-DCs, decreased only slightly upon AdRGD-or conventional Ad infection (Fig 4) . Additionally, AdRGD infection promoted more IL-12 production and secretion in mBM-DCs than conventional Ad infection (Fig 5) . These changes in mBM-DCs were consistent irrespective of the type of transgene sequences inserted into AdRGD or conventional Ad, or transgene transcription. Therefore, we determined that Ad infection directly influenced DC maturation, and the stage of maturation was most likely dependent on the number of Ad particles capable of invading DCs rather than on foreign gene expression in DCs. That is, DC maturation is more effectively induced by AdRGD infection than conventional Ad infection because of the higher infection efficiency of AdRGD. This conjecture is supported by several reports that demonstrated the promotion of DC maturation by Ad infection. [51] [52] [53] In particular, Morelli et al. 54 reported that Ad-infected DCs matured via a NFkB-dependent pathway, regardless of transgenic sequences or Ad-genome transcription. However, Dietz et al. 55 demonstrated that the expression of CD83 and IL-12 p40 was unaffected by Ad infection or transferred gene expression. We presume that the inconsistency might be caused by differences in infection conditions, such as titration of Ad and infection time, although further studies of the relation between Ad infection and DC maturation, which focus on molecular mechanisms, are required.
Immature DCs express CCR1, CCR2, CCR5, and CCR6 in response to inflammatory chemokines produced at the site of tissue injury, whereas mature DCs express CCR7, which is bound by the chemokines CCL19 (ELC/MIP-3b) and CCL21 (SLC/6Ckine). These chemokines are constitutively produced by stromal cells in lymph node. [40] [41] [42] [43] [44] [45] [46] 56, 57 The chemokine receptor expression patterns in DCs are tightly regulated as a function of maturation and account for the differences observed in the roles of immature and mature DCs. Therefore, DC-based immunotherapy should include ex vivo-matured DCs because migration of administered DCs from vaccination site to regional lymph node is an essential part of successful therapy.
Our RT-PCR analysis revealed that immature mBMDCs expressed CCR1, CCR2, CCR5, CCR6, CCR7, and CXCR4 mRNA, and that upregulation and downregulation of CCR7 and CCR6 mRNA expression, respectively, were observed under LPS stimulation (Fig 6) . Recently, Chen et al. 58 used DNA array analysis to demonstrate that CCR7 gene expression was 3.3-fold higher, and that CCR1, CCR2, CCR5, and CXCR4 gene expression was 4.3-, 13-, 7.6-, and 5.9-fold lower, respectively, in mBM-DCs stimulated by 1 mg/ml LPS for 24 hours than in immature cells. Our data on chemokine receptor gene expression patterns in immature mBM-DCs and on CCR7 mRNA upregulation in LPS-stimulated cells agreed with their results. However, we did not observe downregulation of CCR1, CCR2, CCR5, and CXCR4 mRNA levels upon LPS stimulation, because RT-PCR analysis is a less sensitive method for detecting gene expression regulation than DNA array analysis. In addition, the mRNA levels of each chemokine receptor in mBM-DCs infected by Ad were nearly equivalent to those in LPS-stimulated mBMDCs but not in immature mBM-DCs. Therefore, the influence of Ad infection on DC maturation was further supported by the differences in chemokine receptor expression.
In conclusion, our results indicate that AdRGD is superior to conventional Ad in gene transduction efficiency on mBM-DCs, which normally express very little CAR. This is directly linked to the increase in MHC class I-restricted antigen presentation in mBM-DCs. We also demonstrated that the onset and stage of Ad-induced DC maturation may depend on the number of Ad entering the cell but not on foreign gene expression. However, because antigen gene delivery using AdRGD into mBM-DCs is insufficient for inducing maturation, combination with other maturation stimuli is necessary for the development of more effective DC-based immunotherapy. At present, we are attempting to establish DCbased gene immunotherapy methods by taking advantage of AdRGD gene transduction efficiency. DC modification using AdRGD carrying a costimulatory molecule, cytokine, or chemokine receptor gene would enable the reinforcement of T-cell stimulation, control of Th1/Th2 balance, and enhancement of DC migration to lymphoid tissues.
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